Effect of PPAR-Γ agonist-rosiglitazone-on adiponectin level in the metabolic syndrome

Authors :: Mor Oron-Herman
Yehuda Kamari
Ehud Grossman
Yehonatan Sharabi
Irit Avni
Edna Peleg
Source :: American Journal of Hypertension. 18:A204-A204
Publication Year :: 2005
Publisher :: Oxford University Press (OUP), 2005.

Subjects :: medicine.medical_specialty
Adiponectin
medicine.drug_class
business.industry
Insulin
medicine.medical_treatment
Adipokine
medicine.disease
Insulin resistance
Endocrinology
Internal medicine
Diabetes mellitus
Internal Medicine
medicine
Metabolic syndrome
Thiazolidinedione
Rosiglitazone
business
medicine.drug

Full Text Access

Tools